{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:46:30Z","timestamp":1789670790764,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.bmcl.2007.02.076","type":"journal-article","created":{"date-parts":[[2007,3,4]],"date-time":"2007-03-04T06:52:47Z","timestamp":1172991167000},"page":"2769-2774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-\u03b1 converting enzyme (TACE)"],"prefix":"10.1016","volume":"17","author":[{"suffix":"II","given":"James E.","family":"Sheppeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Gilmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Tebben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-Biao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl P.","family":"Decicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.-W.","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2007.02.076_bib1_1","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/S0021-9258(18)89560-6","volume":"260","author":"Aggarwal","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmcl.2007.02.076_bib1_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevImmunol.v16.i1.10","volume":"16","author":"Bemelmans","year":"1996","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.bmcl.2007.02.076_bib2_1","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1517\/13543784.12.7.1097","volume":"12","author":"Braun","year":"2003","journal-title":"Exp. Opin. Invest. Drugs"},{"key":"10.1016\/j.bmcl.2007.02.076_bib2_2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1517\/14656566.2.1.75","volume":"2","author":"Mikuls","year":"2001","journal-title":"Exp. Opin. Pharm."},{"key":"10.1016\/j.bmcl.2007.02.076_bib3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","volume":"385","author":"Black","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2007.02.076_bib4_1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1359-6446(01)01738-X","volume":"6","author":"Moss","year":"2001","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.bmcl.2007.02.076_bib4_2","first-page":"742","volume":"6","author":"Skotnicki","year":"2003","journal-title":"Curr. Opin. Drug Disc. Devel."},{"key":"10.1016\/j.bmcl.2007.02.076_bib5_1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1517\/13543776.15.3.253","volume":"15","author":"Breuer","year":"2005","journal-title":"Exp. Opin. Ther. Patents"},{"key":"10.1016\/j.bmcl.2007.02.076_bib5_2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/0929867013373417","volume":"8","author":"Skiles","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bmcl.2007.02.076_bib5_3","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1021\/cr9804543","volume":"99","author":"Whittaker","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bmcl.2007.02.076_bib6_1","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0960-894X(01)00031-2","volume":"11","author":"Michaelides","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2007.02.076_bib6_2","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1021\/jm010887p","volume":"44","author":"Schroder","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmcl.2007.02.076_bib6_3","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1515\/BC.2001.159","volume":"382","author":"Grams","year":"2001","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bmcl.2007.02.076_bib6_4","unstructured":"Miyata, K.; Kimura, H.; Ishikawa, T.; Yamamoto, K. PCT Int. Appl. WO0172718, 2001."},{"key":"10.1016\/j.bmcl.2007.02.076_bib6_5","unstructured":"Kawamura, N.; Yamashita, T.; Takizawa, M.; Yoshimura, K. JP2000143650, 2000."},{"key":"10.1016\/j.bmcl.2007.02.076_bib7a","volume":"5","author":"Sheppeck","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2007.02.076_bib7b","author":"Sheppeck","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2007.02.076_bib7_3","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1016\/j.bmcl.2005.04.039","volume":"15","author":"Duan","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2007.02.076_bib7_4","author":"Duan","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2007.02.076_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.abb.2006.03.034","volume":"451","author":"Niu","year":"2006","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bmcl.2007.02.076_bib9","first-page":"92","volume":"9","author":"Alves","year":"1996","journal-title":"Pept. Res."},{"key":"10.1016\/j.bmcl.2007.02.076_bib10_1","unstructured":"For the synthesis of 10, 11, 12, see Ref. 7a."},{"key":"10.1016\/j.bmcl.2007.02.076_bib10_2","unstructured":"Compounds 13 and 14 were prepared by coupling the P1\u2032 sulfonyl chloride or P1\u2032 acid chloride to glycine under Schotten-Baumann conditions. The acid was coupled to semicarbazide\u00b7HCl (HATU, Et3N, DMF) followed by treatment with 2M NaOH overnight to give the triazolone."},{"key":"10.1016\/j.bmcl.2007.02.076_bib10_3","unstructured":"(3R,4S)-7 was prepared by coupling the \u03b2-amidopyrrolidinyl carboxylate (prepared in Duan, J.; Ott, G.; Chen, L.; Lu, Z.; Maduskuie, T.P.; Voss, M.E.; Xue, C.-B. WO2001\/070673, 2001) with semicarbazide (HATU, Et3N, DMF) followed by treating with 2M NaOH overnight followed by Boc deprotection with TFA\/DCM."},{"key":"10.1016\/j.bmcl.2007.02.076_bib10_4","unstructured":"Synthesis of 15 started from 2-chloro-1-(2-nitrophenyl)ethanone (Terrier, C.; Mary, A.; Thal, C. Tetrahedron 1994, 50, 6287) which was then treated with KOCN in water at rt for 12h to form the imidazolone (29% yield). Reduction of the nitro group (Pd\/C, MeOH, H2; 100% yield) followed by coupling to the P1\u2032 acid using the same method as used for compounds 6 and 9 provided 15."},{"key":"10.1016\/j.bmcl.2007.02.076_bib13","doi-asserted-by":"crossref","first-page":"11004","DOI":"10.1021\/ja0201810","volume":"124","author":"Cross","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bmcl.2007.02.076_bib14","doi-asserted-by":"crossref","first-page":"8388","DOI":"10.1021\/ja0485513","volume":"126","author":"Puerta","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bmcl.2007.02.076_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00775-004-0524-5","volume":"9","author":"Farkas","year":"2004","journal-title":"J. Biol. Inorg. Chem."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X07002764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X07002764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T05:47:34Z","timestamp":1760766454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X07002764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0960894X07002764"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2007.02.076","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydantoins, triazolones, and imidazolones as selective non-hydroxamate inhibitors of tumor necrosis factor-\u03b1 converting enzyme (TACE)","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2007.02.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}